Cargando…

The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women

The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Fang, Chen, Shouzhen, Gao, Yifei, Dai, Xujing, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655222/
https://www.ncbi.nlm.nih.gov/pubmed/29113327
http://dx.doi.org/10.18632/oncotarget.20384
_version_ 1783273490378391552
author Shen, Fang
Chen, Shouzhen
Gao, Yifei
Dai, Xujing
Chen, Qi
author_facet Shen, Fang
Chen, Shouzhen
Gao, Yifei
Dai, Xujing
Chen, Qi
author_sort Shen, Fang
collection PubMed
description The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian cancer including its subtypes in Chinese women. Data on 1,283 women with primary malignant or borderline ovarian cancer including age at diagnosis, age at menopause and histology from the largest women's hospital in China was analysed. The median age at diagnosis was 53, 44 and 23 years for epithelial ovarian cancer or sex-cord tumors or germ cell tumors respectively. 58% of epithelial ovarian cancers were diagnosed after menopause, while 58% and 95% of sex-cord tumors and germ cell tumors were diagnosed before menopause. Around 60% of serous, endometrioid and clear-cell carcinoma of epithelial ovarian cancer were diagnosed after menopause, while 23% of mucinous carcinoma was diagnosed after menopause. The median age at diagnosis was 35 years for borderline ovarian cancer and 80% of patients were diagnosed before menopause. Our data demonstrates that the median age at diagnosis of ovarian cancer is younger in our study population than Caucasians reported in the literature regardless of malignant or borderline ovarian cancers, and regardless of subtypes of epithelial ovarian cancer. The prevalence of ovarian cancer is proportionately higher in our study population before menopause than Caucasians. Our results suggest clinicians to be more aware of the symptoms of ovarian cancer in premenopausal Chinese women.
format Online
Article
Text
id pubmed-5655222
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56552222017-11-06 The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women Shen, Fang Chen, Shouzhen Gao, Yifei Dai, Xujing Chen, Qi Oncotarget Research Paper The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian cancer including its subtypes in Chinese women. Data on 1,283 women with primary malignant or borderline ovarian cancer including age at diagnosis, age at menopause and histology from the largest women's hospital in China was analysed. The median age at diagnosis was 53, 44 and 23 years for epithelial ovarian cancer or sex-cord tumors or germ cell tumors respectively. 58% of epithelial ovarian cancers were diagnosed after menopause, while 58% and 95% of sex-cord tumors and germ cell tumors were diagnosed before menopause. Around 60% of serous, endometrioid and clear-cell carcinoma of epithelial ovarian cancer were diagnosed after menopause, while 23% of mucinous carcinoma was diagnosed after menopause. The median age at diagnosis was 35 years for borderline ovarian cancer and 80% of patients were diagnosed before menopause. Our data demonstrates that the median age at diagnosis of ovarian cancer is younger in our study population than Caucasians reported in the literature regardless of malignant or borderline ovarian cancers, and regardless of subtypes of epithelial ovarian cancer. The prevalence of ovarian cancer is proportionately higher in our study population before menopause than Caucasians. Our results suggest clinicians to be more aware of the symptoms of ovarian cancer in premenopausal Chinese women. Impact Journals LLC 2017-08-22 /pmc/articles/PMC5655222/ /pubmed/29113327 http://dx.doi.org/10.18632/oncotarget.20384 Text en Copyright: © 2017 Shen et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Shen, Fang
Chen, Shouzhen
Gao, Yifei
Dai, Xujing
Chen, Qi
The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title_full The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title_fullStr The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title_full_unstemmed The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title_short The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
title_sort prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal chinese women
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655222/
https://www.ncbi.nlm.nih.gov/pubmed/29113327
http://dx.doi.org/10.18632/oncotarget.20384
work_keys_str_mv AT shenfang theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT chenshouzhen theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT gaoyifei theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT daixujing theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT chenqi theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT shenfang prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT chenshouzhen prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT gaoyifei prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT daixujing prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen
AT chenqi prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen